PCRX vs AMPH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
PCRX
AMPH
Investment Advisor Scores
AMPH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | AMPH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.8814 | 0 | Tie |
| PEG Ratio | 0.9886 | 2.77 | PCRX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -1.6% | 8.2% | AMPH |
| Earnings Growth | 483.3% | 135.1% | PCRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.9/100 | 31.5/100 | PCRX |
| Profit Margin | 5.1% | 13.3% | AMPH |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | PCRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (17.9% over 20 days), RSI 82
AMPH
MarkupPrice above SMA50, rising 50-day trend (9.8% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | PCRX | AMPH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | 10.8 |
| Trailing P/E | 39.2 | 13.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 0.93 | 2.18 |
| Dividend Yield | — | — |